Dr. Nicole Saphier, Trump’s 3rd surgeon general pick, faces Senate grilling
PUBLISHED Sep 16, 2026, 10:55 AM ET
Read, Watch or Listen
Dr. Nicole Saphier, President Donald Trump’s third nominee for U.S. Surgeon General, faced rigorous questioning before the Senate Health, Education, Labor, and Pensions Committee on Wednesday. Lawmakers pressed the radiologist and former Fox News contributor on her capacity to navigate the public health agenda of Health and Human Services Secretary Robert F. Kennedy Jr., specifically regarding standard vaccination schedules amid rising measles outbreaks. While Saphier has historically questioned certain vaccine mandates and routine infant shots, she has distanced herself from fringe conspiracy theories and criticized unscientific health messaging, such as blanket warnings on Tylenol use during pregnancy. Additionally, senators scrutinized her financial disclosures, which revealed substantial holdings in corporate healthcare, processed foods, and insurance, alongside ownership in an unregulated herbal extract firm. Saphier agreed to divest these assets upon confirmation. Her nomination follows the stalled or withdrawn bids of previous choices Janette Nesheiwat and Casey Means.
By Ayesha A. | JQJO News
Timeline of Events
- On April 30 2026 President Trump nominated Dr. Nicole Saphier as surgeon general.
- On September 16 2026 Saphier faced intense questioning before Senate health committee today.
- On September 16 2026 Lawmakers scrutinized her financial holdings and vaccine skepticism positions.
- On September 16 2026 Committee members questioned her alignment with HHS Secretary Kennedy.
- On May 1 2026 Advisory Board reported Saphier replacing Casey Means as nominee.
- On April 30 2026 CBS News covered Trump withdrawing Casey Means stalled nomination.
- On February 25 2026 Previous nominee Casey Means testified before Senate committee.
- On May 1 2025 Initial nominee Janette Nesheiwat was withdrawn amid credential queries.
- On January 1 2020 Saphier authored the book Make America Healthy Again.
- On January 1 2022 Saphier criticized anticipated pandemic school vaccine mandate policy shifts.
- Future Senate votes will determine Saphier's confirmation status in coming months.
News Intelligence
- Immediate US impact: Highlights confirmation friction for federal public health leadership positions.
- Possible long-term US impact: Shapes federal health policy alignment with alternative wellness movements.
- Most affected groups: Federal health agencies, medical professionals, and pharmaceutical industry investors.
- Reader priority: Track Senate committee votes and official financial disclosure divestiture filings.
- Articles Published:
- 29
- Right Leaning:
- 5
- Left Leaning:
- 4
- Neutral:
- 20
- Distribution:
- Left 14%, Center 69%, Right 17%
Left: Emphasized potential conflicts of interest and skepticism toward public health. Center: Highlighted confirmation hearing details, vaccine stances, and financial disclosures objectively. Right: Emphasized her medical background and alignment with health reform goals.
Associated Press published report on Senate hearing for nominee Saphier. https://apnews.com/article/trump-nicole-saphier-surgeon-general-healthcare-c1da4b1805ac33850e891c4459e0a5a9
Coverage of Story:
From Left
Trump's third surgeon general nominee, Nicole Saphier, to face Senate
The Washington Post The Guardian New York Times HuffPostFrom Center
Dr. Nicole Saphier, Trump's 3rd surgeon general pick, faces Senate grilling
Associated Press CBS News KFF Health News Medical Economics MedPage Today Politico The Hill NBC News Reuters Bloomberg USA Today Chicago Tribune Forbes Axios Time Newsweek The Messenger Bloomberg Government Modern Healthcare Fierce HealthcareFrom Right
WATCH LIVE: Trump’s pick for surgeon general appears for confirmation hearing
Washington Examiner Wall Street Journal Washington Times Daily Wire Townhall
Comments